These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 32514431)

  • 41. COVID-19 vaccine-induced antibody and T-cell responses in immunosuppressed patients with inflammatory bowel disease after the third vaccine dose (VIP): a multicentre, prospective, case-control study.
    Alexander JL; Liu Z; Muñoz Sandoval D; Reynolds C; Ibraheim H; Anandabaskaran S; Saifuddin A; Castro Seoane R; Anand N; Nice R; Bewshea C; D'Mello A; Constable L; Jones GR; Balarajah S; Fiorentino F; Sebastian S; Irving PM; Hicks LC; Williams HRT; Kent AJ; Linger R; Parkes M; Kok K; Patel KV; Teare JP; Altmann DM; Goodhand JR; Hart AL; Lees CW; Boyton RJ; Kennedy NA; Ahmad T; Powell N;
    Lancet Gastroenterol Hepatol; 2022 Nov; 7(11):1005-1015. PubMed ID: 36088954
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Latin American consensus on the quality indicators for comprehensive care clinics for patients with inflammatory bowel disease: PANCCO-GETECCU.
    Yamamoto-Furusho JK; Andrade D; Barahona J; Bautista S; Bosques-Padilla F; de Paula J; Galiano MT; Iade B; Juliao-Baños F; Otoya G; Steinwurz F; Torres E; Veitia G; Barreiro-de Acosta M
    Rev Gastroenterol Mex (Engl Ed); 2022; 87(1):89-102. PubMed ID: 34866040
    [TBL] [Abstract][Full Text] [Related]  

  • 43. A national survey on the patterns of treatment of inflammatory bowel disease in Canada.
    Hilsden RJ; Verhoef MJ; Best A; Pocobelli G
    BMC Gastroenterol; 2003 Jun; 3():10. PubMed ID: 12791168
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Crohn's and Colitis Canada's 2021 Impact of COVID-19 and Inflammatory Bowel Disease in Canada: COVID-19 Vaccines-Biology, Current Evidence and Recommendations.
    Murthy SK; Kuenzig ME; Windsor JW; Ghia JE; Griffiths AM; Panaccione R; Seow CH; Benchimol EI; Bernstein CN; Bitton A; Huang JG; Jones JL; Lee K; Kaplan GG; Mukhtar MS; Tandon P; Targownik LE; Gibson DL
    J Can Assoc Gastroenterol; 2021 Dec; 4(Suppl 2):S54-S60. PubMed ID: 34755040
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Recovery from COVID-19 Pneumonia in a Patient with Acute Severe Colitis.
    Garcia KS; Moutinho BD; de Azevedo MFC; Queiroz NSF; Milani LR; Sanches LN; Barros LL; Oba J; Carlos AS; Damião AOMC; Sipahi AM
    Inflamm Intest Dis; 2020 Jun; 5(2):93-97. PubMed ID: 32984404
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Guidelines for the management of inflammatory bowel disease in adults.
    Mowat C; Cole A; Windsor A; Ahmad T; Arnott I; Driscoll R; Mitton S; Orchard T; Rutter M; Younge L; Lees C; Ho GT; Satsangi J; Bloom S;
    Gut; 2011 May; 60(5):571-607. PubMed ID: 21464096
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Impact of COVID-19 on diagnosis and management of paediatric inflammatory bowel disease during lockdown: a UK nationwide study.
    Ashton JJ; Kammermeier J; Spray C; Russell RK; Hansen R; Howarth LJ; Torrente F; Deb P; Renji E; Muhammed R; Paul T; Kiparissi F; Epstein J; Lawson M; Hope B; Zamvar V; Narula P; Kadir A; Devadason D; Bhavsar H; Beattie RM
    Arch Dis Child; 2020 Dec; 105(12):1186-1191. PubMed ID: 32732316
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Immunosuppressive therapy in pediatric inflammatory bowel disease: results of a survey of the North American Society for Pediatric Gastroenterology and Nutrition. Subcommittee on Immunosuppressive Use of the Pediatric IBD Collaborative Research Forum.
    Markowitz J; Grancher K; Mandel F; Daum F
    Am J Gastroenterol; 1993 Jan; 88(1):44-8. PubMed ID: 8420272
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Changes in the management of IBD patients since the onset of COVID-19 pandemic. A path toward the implementation of telemedicine in Spain?
    Del Hoyo J; Millán M; Garrido-Marín A; Nos P; Barreiro-de Acosta M; Bujanda L; de la Portilla F; Aguas M;
    Gastroenterol Hepatol; 2022 Nov; 45(9):697-705. PubMed ID: 34508808
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Activities related to inflammatory bowel disease management during and after the coronavirus disease 2019 lockdown in Italy: How to maintain standards of care.
    Saibeni S; Scucchi L; Dragoni G; Bezzio C; Miranda A; Ribaldone DG; Bertani A; Bossa F; Allocca M; Buda A; Mocci G; Soriano A; Mazzuoli S; Bertani L; Baccini F; Loddo E; Privitera AC; Sartini A; Viscido A; Grossi L; Casini V; Gerardi V; Ascolani M; Ruscio MD; Casella G; Savarino E; Stradella D; Pumpo R; Cortelezzi CC; Daperno M; Ciardo V; Nardone OM; Caprioli F; Vitale G; Cappello M; Comberlato M; Alvisi P; Festa S; Campigotto M; Bodini G; Balestrieri P; Viola A; Pugliese D; Armuzzi A; Fantini MC; Fiorino G;
    United European Gastroenterol J; 2020 Dec; 8(10):1228-1235. PubMed ID: 33070758
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Anxiety and behavioral changes in Japanese patients with inflammatory bowel disease due to COVID-19 pandemic: a national survey.
    Nakase H; Wagatsuma K; Nojima M; Matsumoto T; Matsuura M; Iijima H; Matsuoka K; Ohmiya N; Ishihara S; Hirai F; Takeuchi K; Tamura S; Kinjo F; Ueno N; Naganuma M; Watanabe K; Moroi R; Nishimata N; Motoya S; Kurahara K; Takahashi S; Maemoto A; Sakuraba H; Saruta M; Tominaga K; Hisabe T; Tanaka H; Terai S; Hiraoka S; Takedomi H; Narimatsu K; Endo K; Nakamura M; Hisamatsu T
    J Gastroenterol; 2023 Mar; 58(3):205-216. PubMed ID: 36607399
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Recommendations of the Spanish Working Group on Crohn's Disease and Ulcerative Colitis (GETECCU) and the Association of Crohn's Disease and Ulcerative Colitis Patients (ACCU) in the management of psychological problems in Inflammatory Bowel Disease patients.
    Barreiro-de Acosta M; Marín-Jiménez I; Panadero A; Guardiola J; Cañas M; Gobbo Montoya M; Modino Y; Alcaín G; Bosca-Watts MM; Calvet X; Casellas F; Chaparro M; Fernández Salazar L; Ferreiro-Iglesias R; Ginard D; Iborra M; Manceñido N; Mañosa M; Merino O; Rivero M; Roncero O; Sempere L; Vega P; Zabana Y; Mínguez M; Nos P; Gisbert JP
    Gastroenterol Hepatol; 2018 Feb; 41(2):118-127. PubMed ID: 29275001
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Canadian Association of Gastroenterology Clinical Practice Guideline for Immunizations in Patients With Inflammatory Bowel Disease (IBD)-Part 2: Inactivated Vaccines.
    Jones JL; Tse F; Carroll MW; deBruyn JC; McNeil SA; Pham-Huy A; Seow CH; Barrett LL; Bessissow T; Carman N; Melmed GY; Vanderkooi OG; Marshall JK; Benchimol EI
    Gastroenterology; 2021 Aug; 161(2):681-700. PubMed ID: 34334167
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Addendum to S3-Guidelines Crohn's disease and ulcerative colitis: Management of Patients with Inflammatory Bowel Disease in the COVID-19 Pandemic - open questions and answers.
    Stallmach A; Sturm A; Blumenstein I; Helwig U; Koletzko S; Lynen P; Schmidt C; Dignass A; Kucharzik T;
    Z Gastroenterol; 2020 Oct; 58(10):982-1002. PubMed ID: 33036052
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Inflammatory bowel disease biopsies: updated British Society of Gastroenterology reporting guidelines.
    Feakins RM;
    J Clin Pathol; 2013 Dec; 66(12):1005-26. PubMed ID: 23999270
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Understanding attitudes, concerns, and health behaviors of patients with inflammatory bowel disease during the coronavirus disease 2019 pandemic.
    Goodsall TM; Han S; Bryant RV
    J Gastroenterol Hepatol; 2021 Jun; 36(6):1550-1555. PubMed ID: 33063927
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Recommendations of the Spanish Group on Crohn's Disease and Ulcerative Colitis on the importance, screening and vaccination in inflammatory bowel disease patients.
    Ferreiro-Iglesias R; Piqueras M; Ricart E; Sempere L; Roca M; Martín de Carpi J; Benítez O; Zabana Y; Mañosa M; Rodríguez-Moranta F; Barreiro-de Acosta M;
    Gastroenterol Hepatol; 2022 Dec; 45(10):805-818. PubMed ID: 35577225
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Effect of anti-SARS-CoV-2 BNT162b2 mRNA vaccination on thrombin generation in children with inflammatory bowel disease.
    Stercel V; Lóczi L; Kadenczki O; Nemes É; Nagy B; Hodossy-Takács R; Szabó AÁ; Fagyas M; Kappelmayer J; Szabó T; Bagoly Z
    Front Immunol; 2023; 14():1257072. PubMed ID: 37965328
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Inflammatory bowel disease and SARS-CoV-2 pandemic: current knowledge and recommendations.
    Bekic D; Belosic Halle Z
    Scand J Gastroenterol; 2021 Jun; 56(6):656-660. PubMed ID: 33765405
    [TBL] [Abstract][Full Text] [Related]  

  • 60. COVID-19 Vaccine Hesitancy among Patients with Inflammatory Bowel Disease Receiving Biologic Therapies in Kuwait: A Cross-Sectional Study.
    Shehab M; Zurba Y; Al Abdulsalam A; Alfadhli A; Elouali S
    Vaccines (Basel); 2021 Dec; 10(1):. PubMed ID: 35062716
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.